Introduction
============

Circling mice (C57BL/6J-cir), an animal model of deafness inherited in an autosomal recessive manner due to spontaneous mutation of non-syndromic recessive deafness family loci has pathogenomic lesions portraying spiral ganglion cell degeneration in the cochlea, empty Rosenthal canal ascribing in severe degeneration of the axons between hair cells and spiral ganglion cells, and loss of organ of Corti ([@b1-mmr-12-06-7927]). Around postnatal day 7, the circling mice became hyperactive and exhibited head tossing, tail chasing and circling behavior ([@b1-mmr-12-06-7927]). These characteristic behaviors were observed in the homozygote (cir/cir) mice only.

Deafness is known to be associated with alterations in the auditory pathways ([@b2-mmr-12-06-7927]), which may reflect the decrease in synaptic plasticity, marked changes in neurotransmitters, including D-aspartate ([@b3-mmr-12-06-7927]), glycine ([@b4-mmr-12-06-7927]), gamma-amino butyric acid ([@b5-mmr-12-06-7927]), N-Methyl-D-aspartic acid (NMDA), including its receptors (e.g. NMDAR1) ([@b6-mmr-12-06-7927]), and ion channels ([@b7-mmr-12-06-7927]). Additionally, synapse associated proteins, including protein kinases ([@b8-mmr-12-06-7927]), calbindin ([@b9-mmr-12-06-7927]), extracellular signal-related kinase and stress-activated protein kinases ([@b10-mmr-12-06-7927]), may affect auditory functions. Owing to these changes, the imbalances between excitation and inhibition signals critically affect the neuronal response ([@b11-mmr-12-06-7927]) and tonotopic map profile ([@b12-mmr-12-06-7927]).

Glycine is a major inhibitory neurotransmitter in the brain-stem and acts through the strychnine-sensitive glycine receptor (GlyR) ([@b13-mmr-12-06-7927]), involved in various fundamental physiological processes ([@b14-mmr-12-06-7927]). Within the brainstem, glycinergic neurotransmission is essential, particularly in the auditory nuclei ([@b15-mmr-12-06-7927]), for several aspects of neuronal function ([@b16-mmr-12-06-7927]) being involved in basic function, including sound localization or lateral inhibition ([@b17-mmr-12-06-7927]). Lateral superior olive (LSO), a major nucleus of superior olivary complex (SOC) receives bilateral innervation and along with medial nucleus of the trapezoid body (MNTB), medial superior olive (MSO) and superior paraolivary nucleus (SPN), is an important part of hearing, since it is at this level in the ascending auditory pathway where binaural processing of sound localization cues initially occur ([@b18-mmr-12-06-7927]). MNTB provides inhibitory input to LSO and imparts sensitivity to interaural intensity differences in LSO cells ([@b19-mmr-12-06-7927]). Marked glycinergic input is also provided to the SPN by MNTB ([@b20-mmr-12-06-7927]), whose neurons display offset responses to pure tones.

Alteration of the glycinergic synapses in the auditory pathways due to hearing loss by cochlear ablation and middle ear ossicle removal loss has been reported to induce regulatory changes in the synaptic release and uptake of glycine in the brain stem nuclei and GlyR binding ([@b4-mmr-12-06-7927],[@b21-mmr-12-06-7927],[@b22-mmr-12-06-7927]). Age-associated hearing loss is also associated with decreased glycine-immunoreactive neurons and puncta ([@b23-mmr-12-06-7927]), and changes in the GlyR subunits ([@b24-mmr-12-06-7927]). A decrease in the GlyR has been reported to lead to improper functioning, particularly in the brainstem region in specific SOC nuclei following deafness ([@b21-mmr-12-06-7927],[@b25-mmr-12-06-7927]). As glycine is implicated in the deafness-associated decrease in the inhibition in the SOC, understanding its distribution in a deafness model, including circling mice, may further elucidate this.

Inhibitory glycinergic synapses in adult rodents at MNTB-LSO synapses ([@b21-mmr-12-06-7927],[@b26-mmr-12-06-7927]) release glutamate as the predominant neurotransmitter from birth ([@b27-mmr-12-06-7927]). However, its release in the cir/cir mouse is sustained at a later period of development ([@b28-mmr-12-06-7927]). This sustenance of the glutamatergic transmission in the later period of developing the MNTB-LSO synapse in cir/cir in mature animals ([@b29-mmr-12-06-7927]) may also contribute to changes in the distribution of GlyR in the brainstem region of the cir/cir mice. Previous studies have suggested an activity-dependent deafness-associated decrease in glycine in the SOC ([@b21-mmr-12-06-7927],[@b24-mmr-12-06-7927]). A previous study of GlyR immunoreactivity (IR) in circling mice was performed in the LSO nuclei at p16 ([@b28-mmr-12-06-7927]), however, no studies have been reported in the SOC nuclei as a whole. Although GlyR IR appears in all the SOC nuclei except MSO at p8 in rodents, mature staining is obtained only following p21 ([@b30-mmr-12-06-7927]). Therefore, considering the sustenance of glutamatergic transmission and deafness-associated GlyR decrease with the lack of studies of GlyR IR in the adult circling mice, the present study used immunohistochemical analysis to detect any possible histopathological changes and to compare the GlyR IR, cell number and the cell size in four SOC regions, LSO, SPN, MSO and MNTB, between adult +/cir and cir/cir mice.

Materials and methods
=====================

Animal experimentation
----------------------

The present study used 10 adult male mice (+/cir, n=5; cir/cir, n=5; Orientbio, Inc., Daejeon, Korea). All animal procedures were performed according to the NIH guidelines of animal research ([@b31-mmr-12-06-7927]) and were approved by Dankook University Institutional Animal Care and Use Committee, which adheres to the guidelines issued by the Institution of Laboratory of Animal Resources.

Polymerase chain reaction (PCR)
-------------------------------

PCR analysis was performed to differentiate between the +/cir and cir/cir mice using genomic DNA obtained from mouse tails. The genomic DNA was isolated, according to the manufacturer\'s instructions (Bioneer, Daejeon, Korea). The cir/cir mouse was identified by the absence of the *tmie* gene. PCR was performed with primers designed to amplify the exon 1 coding region of the *tmie* gene (forward: 5′-AGCTGTAGCTCTGAAATCT-3′ and reverse: 5′-TCTGGCAGAATGCATGGAGGCT-3′). A total of 100 ng template DNA was used in a final reaction volume of 20 *µ*l \[10 mM Tris-HCl (pH 9.0), 40 mM KCl, 1.5 mM MgCl~2~, 250 mM dNTP, 20 pmol each primer and 1 unit Taq DNA polymerase; Bioneer Corporation, Daejeon, Korea\]. PCR was performed in a thermal cycler (C1000TM; Bio-Rad Laboratories, Singapore) in two stages. The first stage consisted of four cycles of denaturation at 96°C for 5 min, annealing at 59°C for 1 min and extension at 72°C for 1 min. The second stage included 30 cycles of denaturation at 96°C for 1 min, annealing at 59°C for 1 min and extension at 72°C for 1 min, followed by a final extension at 72°C for 10 min. Electrophoresis was performed at 93 V for 1 h at 25°C to identify the amplification fragments.

Immunohistochemical procedure
-----------------------------

Following perfusion, the brains were immediately removed, post-fixed overnight in 4% paraformaldehyde and cryoprotected by infiltration with a sucrose series (10, 20 and 30%) at 4°C. Serial coronal sections of 40 *µ*m thickness were obtained on a freezing sliding microtome (Leica Microsystems Ltd., Seoul, Korea) and were collected in 6-well plates. Immunohistochemistry was performed using the free floating method, as described previously ([@b31-mmr-12-06-7927]). The brain areas were identified based on the atlas of the mouse brain by Paxinos and Franklin ([@b32-mmr-12-06-7927]). Briefly, coronal sections were incubated for 48 h at 4°C in rabbit polyclonal antibodies against glycine receptor α1/2 (1:2,500; cat. no. ab23809; Abcam, Cambridge, UK) diluted in blocking buffer, containing 1% bovine serum albumin, 0.3% Triton X-100 and 1% normal horse serum. To eliminate peroxidase activity, the sections were treated with 10% hydrogen peroxide in phosphate-buffered saline (PBS). The sections were incubated with biotinylated goat anti-rabbit IgG antibody (cat. no. BA-1000; Vector Laboratories, Inc., Burlingame, CA, USA) at a dilution of 1:250 for 1.5 h at room temperature, followed by treatment with an avidin-biotin-peroxidase complex (Vectastain ABC mouse Elite kit; Vector Laboratories, Burlingame, CA, USA). Following three washes in PBS, the sections were incubated with 3,3′-diaminobenzidine and hydrogen peroxide in a distilled water solution for 5 min. The sections from each group were stained together to minimize variability. Following additional washes, the sections were mounted onto gelatin coated slides, dehydrated in a solution of increasing ethanol, cleared in xylene and cover slipped with mounting solution (SP15500; Thermo Fisher Scientific, New Jersey, NJ, USA).

Image analysis
--------------

A BX51 microscope (Olympus, Tokyo, Japan) was used for the analysis and images were captured using a digital camera system (DP50; Olympus). Staining densities were determined using NIH image program, version 1.44 (Scion Image; Scion Corporation, Bethesda, MA, USA), as described previously ([@b31-mmr-12-06-7927]). Cell counting was performed using a manual cell counting and marking method, and measurement of cell size (area) was performed using ImageJ version 1.44 software (National Institute of Health, Bethesda, MD, USA). The analysis of the slides was performed by an investigator in a blinded manner.

Statistical analysis
--------------------

Student\'s t-test was performed using SPSS 17.0 software (SPSS, Inc., Chicago, IL, USA). P\<0.05 was considered to indicate a statistically significant difference. The data are expressed as the mean ± standard deviation. A comparison between +/cir and cir/cir mice was performed for the LSO, SPN and MNTB region from each of the 10 sections assessed in each group to measure the GlyR IR, cell counting and cell area.

Results
=======

Histopathological observations
------------------------------

Intense GlyR IR was observed in all the major nuclei of the SOC in LSO, SPN, MSO and MNTB of +/cir ([Fig. 1](#f1-mmr-12-06-7927){ref-type="fig"}). GlyR IR was located in the soma, as well as the neuropil, of the LSO region, while it was predominantly located in the soma in the remaining nuclei ([Fig. 1A, C and D](#f1-mmr-12-06-7927){ref-type="fig"}). Intensely labeled immunoreactive puncta surrounded the soma of these neurons, leaving perikarya unlabeled ([Fig. 2](#f2-mmr-12-06-7927){ref-type="fig"}). The puncta were restricted to the soma and were not present in the dendrites or the neuropil. Mostly bipolar cells, with eccentric nuclei, were observed in the LSO and MSO region, while the SPN comprised bipolar, as well as a few multipolar neurons ([Fig. 2I, K, M and O](#f2-mmr-12-06-7927){ref-type="fig"}). The neuropil of the SPN and MSO contained numerous GlyR immunoreactive fibers running in between the stained cells ([Fig. 2K and M](#f2-mmr-12-06-7927){ref-type="fig"}). MNTB exhibited a membrane localization staining pattern with punctuate staining, however, dense patchy staining was prominently visible within the soma on the lateral aspect of MNTB.

Compared with +/cir, the cir/cir cells exhibited a very prominent loss of GlyR IR in the soma, as well as the neuropil ([Fig. 1B, D and F](#f1-mmr-12-06-7927){ref-type="fig"}). Prominent loss of GlyR staining was evident in the neuropil of the LSO of cir/cir, which was markedly more severe in the lateral limb of the LSO compared with the medial limb, while the neurons of the LSO, SPN and MNTB also revealed marked decrement in the GlyR IR. A marked loss of staining was noted in the dendrites of the neurons of the LSO and SPN region ([Fig. 2J and K](#f2-mmr-12-06-7927){ref-type="fig"}). The GlyR immunoreactive fibers also appeared to be absent in the SPN of the cir/cir cells. A decrease in cell number, as well as cell size, was noted in the different nuclei of the SOC of the cir/cir cells ([Fig. 2J, K, L and P](#f2-mmr-12-06-7927){ref-type="fig"}).

IR analysis
-----------

According to the relative density, the GlyR IR in the SOC region was markedly decreased in all the major nuclei of cir/cir, as compared with +/cir. The GlyR IR in the LSO region was 121.82±2.40 in +/cir, which was significantly decreased by 7.32% to 112.89±2.95 in cir/cir (P\<0.0001; [Fig. 3A](#f3-mmr-12-06-7927){ref-type="fig"}). Compared with +/cir, a significant decrement from 108.35±3.09 of 6.2% was noted in cir/cir (101.54±2.74; P\<0.0001; [Fig. 3A](#f3-mmr-12-06-7927){ref-type="fig"}). A significant decrease in the GlyR IR was also observed from 133.21±4.15 in +/cir to 125.71±4.22 in cir/cir, which amounted to 7.49% (P\<0.001; [Fig. 3A](#f3-mmr-12-06-7927){ref-type="fig"}). A significant 12.07% decrease to 101.63±3.46 in cir/cir from 113.70±4.08 in +/cir was demonstrated (P\<0.0001).

Cell numbers
------------

GlyR immunoreactive cells in the SOC region of +/cir were compared with those from cir/cir. A trend of significant loss of GlyR immunoreactive cells was noted in the cir/cir cells. In the LSO region, a significant 25.30% decrease from 148.6±14.80 in +/cir to 111±12.60 in cir/cir (P\<0.005; [Fig. 3B](#f3-mmr-12-06-7927){ref-type="fig"}) was observed. A significant 26.63% loss of GlyR immunoreactive cells was also noted in the SPN region, decreasing from 48.8±4.65 in +/cir to 35.8±5.71 in cir/cir (P\<0.005; [Fig. 3B](#f3-mmr-12-06-7927){ref-type="fig"}). MSO exhibited a 39% loss, decreasing from 20±4.35 in +/cir to 12.2±1.92 in cir/cir (P\<0.01). MNTB, by far, exhibited the least decrement of 16.91% with 149±8.68 in +/cir and 123.8±7.19 in cir/cir (P\<0.001), although the IR loss was the most severe in MNTB compared with the other SOC regions ([Fig. 3B](#f3-mmr-12-06-7927){ref-type="fig"}).

Cell size
---------

The size of the cells present in each nuclei of the SOC was compared between the +/cir and cir/cir groups. No significant difference was observed in the LSO and MSO region of cir/cir, although a trend of decrease was noted in each nuclei. A 2.12% decrement was observed in the LSO from 233.16±14.28 to 228.21±13.71 *µ*m^2^ ([Fig. 3C](#f3-mmr-12-06-7927){ref-type="fig"}). Similarly, the MSO region also exhibited a 4.94% decrement from 209.10±15.21 in +/cir to 198.76±25.85 *µ*m^2^ in cir/cir ([Fig. 3C](#f3-mmr-12-06-7927){ref-type="fig"}). However, in the SPN, a significant decrease of 4.85% was noted from 438.70±19.13 in +/cir to 417.51±17.80 *µ*m^2^ in cir/cir (P\<0.01). Similarly, principal cells in the MNTB region exhibited a significant 9.44% decrement in the cir/cir as compared with +/cir from 414.35±23.18 to 375.20±34.72 *µ*m^2^, respectively (P\<0.01; [Fig. 3C](#f3-mmr-12-06-7927){ref-type="fig"}).

Discussion
==========

The present study revealed a decrease in the GlyR IR, as well as GlyR immunoreactive cell number and cell size in the SOC nuclei of cir/cir when compared with +/cir. This is consistent with previous reports of deafness-associated decreases in the Gly immunoreactive cells in the SOC ([@b25-mmr-12-06-7927]).

A decrease in the GlyR in cir/cir may be a consequence of the decrease in the glycine levels, which may possibly lower the immunocytochemical detection or it may be due to a physical reduction in the number of the GlyR immunoreactive cells, as well as the decrease in the cell size, as noted in the present study. This may be the result of an activity-dependent decrease following deafness, associated with decreased activity. Pruning of glycinergic terminals in LSO and MSO ([@b33-mmr-12-06-7927]) due to experience-dependent plasticity is also possible, particularly due to sustenance of glutamatergic transmission in cir/cir, although it has been hypothesized to be a temporary phase ([@b28-mmr-12-06-7927]). Readjustments in the location of glycine immunoreactive terminals with terminals moving from soma to dendrites has been previously reported ([@b34-mmr-12-06-7927]), however the loss of dendritic staining in the cir/cir firmly rejects this hypothesis. Furthermore, even without the quantitative assessment of the GlyR immunoreactive puncta in the present study, a qualitative decrement was noted in all SOC nuclei. A qualitative and quantitative study of glycine immunoreactive axo-somatic puncta may assist in clarifying these issues.

Bilateral deafness, induced by intrascalar injection of neomycin in rats, causes a significant decrease in glycine IR in the nuclei of SOC ([@b25-mmr-12-06-7927]). A significant decrement in the number of glycine immunoreactive puncta on the somata of principal cells was reported, which may be due to transneuronal degeneration, as observed in the SOC following cochlear damage ([@b3-mmr-12-06-7927],[@b35-mmr-12-06-7927]). However, unilateral deafening produced no changes in glycine release in LSO or MNTB, however, this was noted in the cochlear nucleus (CN) ([@b21-mmr-12-06-7927]). Bilateral deafness, as in cir/cir, caused a significant decrease of GlyR in the SOC and CN (unpublished data). This difference may be contributed to the bilateral innervation received by the SOC nuclei from both ipsilateral and contralateral CNs. Cochlear ablation also results in a decrease in glycine release in the CNs ([@b4-mmr-12-06-7927],[@b21-mmr-12-06-7927],[@b36-mmr-12-06-7927]), suggesting that the decreased inhibition following deafness may be associated with the decrease in glycine. Previous studies have suggested deafness as a factor influencing the intracellular pathways modulating neurotransmitters and their release.

The present study revealed a significant percentage decrease of GlyR IR, as well as in cell number and cell size, in the SOC. This decrement was higher for LSO and MNTB in all three aspects, which is particularly important, taking into consideration the importance of MNTB-LSO synapses. SOC uses glycine as major inhibitory neurotransmitter with the majority of the glycinergic pathway originating in the MNTB ([@b37-mmr-12-06-7927]), while balance in the LSO between glycinergic inhibition and glutamatergic excitation from the CN is important for detection of interaural level differences, which appears to be imbalanced in cir/cir due to sustained glutamatergic transmission ([@b28-mmr-12-06-7927]). Indeed, deafness-associated changes in the potential regulators of transmitter release has been reported in the auditory brainstem ([@b10-mmr-12-06-7927],[@b38-mmr-12-06-7927]) and is supported by the immunohistochemical results of the present study.

The LSO receives excitatory projections from ipsilateral and inhibitory from contralateral projections ([@b39-mmr-12-06-7927]). Inhibitory projection arises from homogeneous glycinergic nuclei, MNTB projects topographically along the LSO frequency axis, while the excitatory projection emerges from CN is glutamatergic whose tonotopic projection matches perfectly with inhibitory projection from MNTB, allowing LSO neurons to respond selectively to interaural level differences. The inactivity of GlyR led to a significant decrease in the number of cell surface receptor clusters on cultured spinal cord neurons ([@b40-mmr-12-06-7927]), suggesting that the loss of the glycinergic inhibitor induces change/redistribution of postsynaptic membrane GlyRs. Hearing loss leads to severe long term weakening of glycinergic synaptic inhibition in the LSO, contributing to the downregulation of synaptic release of glycine in dorsal CN and downregulation of postsynaptic GlyR activity in the LSO ([@b5-mmr-12-06-7927]). Hence, a decrease in the GlyR IR in the neurons and neuropil, and a decrease in cell number and size, as noted in the cir/cir, may lead to a decrease in inhibitory transmission leading to profound changes in the functional properties in the SOC nuclei particularly at LSO and MNTB. The data from electrophysiological experiments and electron microscopy in adult circling mice may assist in further elucidating the association between the GlyR and neural function associated with deafness.
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![Immunohistochemical localization of GlyRα1 and α2 IR in coronal sections through the SOC comprising (A and B) LSO, (C and D) SPN and MSO, and (E and F) MNTB of heterozygote (A, C and E) and homozygote (B, D and F) circling mice. GlyR IR was observed in the neurons and neuropil of (A and B) LSO, (C and D) SPN and MSO, and (E and F) MNTB of +/cir and cir/cir mice. Compared with +/−, loss of GlyR IR was observed in all nuclei and neuropil of the cir/cir mice. (Scale bar, 100 *µ*m). SOC, superior olivary complex; LSO, lateral superior olive; SPN, superior paraolivary nucleus; MSO, medial superior olive; MNTB, medial nucleus of the trapezoid body; GlyR, glycine receptor; IR, immunoreactivity.](MMR-12-06-7927-g00){#f1-mmr-12-06-7927}

![Magnified image of GlyRα1 and α2 IR in coronal sections through the SOC comprising (A, B, I and J) LSO, (C, D, K and L) SPN, (E, F, M and N) MSO and (G, H, O and P) MNTB of +/cir (A, C, E, G, I, K, M and O) and cir/cir (B, D, F, H, J, K, L and P) mice. Scattered highly GlyR IR was noted in all nuclei of SOC. Puncta (arrows) possibly indicate presynaptic terminals. A loss of GlyR immunoreactive cells was noted in the (B and J) LSO, (D and K) SPN, (F and N) MSO and (H and P) MNTB of cir/cir mice. A decrease in the size of the soma of cir/cir mice was observed, compared with +/cir mice (Scale bar, A--H, 50 *µ*m; I--P, 10 *µ*m.). SOC, Superior Olivary Complex; LSO, Lateral Superior Olive; SPN, Superior Paraolivary Nucleus; MSO, Medial Superior Olive; MNTB, Medial Nucleus of the Trapezoid Body; IR, immunoreactivity.](MMR-12-06-7927-g01){#f2-mmr-12-06-7927}

![Graph demonstrating the image analysis of (A) relative density, (B) cell number and (C) cell size of glycine receptor α1 and 2 in the various different regions (Lateral Superior Olive, Superior Paraolivary Nucleus, Medial Superior Olive and Medial Nucleus of the Trapezoid Body) of the superior olivary complex of adult heterozygous (+/cir), and homozygous (cir/cir) circling mice (^\*^P\<0.01, ^\*\*^P\<0.001, ^\*\*\*^P\<0.005 and ^\*\*\*\*^P\<0.0001, compared with the heterozygote).](MMR-12-06-7927-g02){#f3-mmr-12-06-7927}
